Combining these latter aspects (weight loss, BMI, SGA and serum albumin levels) suggested that the Nutritional Risk Index (NRI) could represent an index to predict good or bad prognosis in patients undergoing chemotherapy, even if future validation of specific tests for cancer patients is needed [83]. This evidence concerns the gene ALB and cancer.